Literature DB >> 25107540

Early axonal damage detection by ganglion cell complex analysis with optical coherence tomography in nonarteritic anterior ischaemic optic neuropathy.

Begoña Arana Larrea1, Marta Galdos Iztueta, Lorea Martinez Indart, Nerea Martinez Alday.   

Abstract

PURPOSE: To investigate the ability of ganglion cell complex (GCC) analysis by optical coherence tomography (OCT) to detect early axonal damage in nonarteritic anterior ischaemic optic neuropathy (NAION), and to assess the relationship of GCC measurements with visual field defects and function parameters.
METHODS: Twenty-two patients with NAION participated in this retrospective case-series study. Patients underwent spectral-domain OCT measurement of retinal nerve fibre layer (RNFL) and GCC average and minimum thicknesses, best-corrected visual acuity, Ishihara test and Humphrey visual field (SITA Standard 24-2). These measurements were recorded in the acute (2-6 weeks after the ischaemic episode) and chronic (≥6 months later) phases. Spearman's coefficients were used to assess the relationship between GCC thickness and visual field defects.
RESULTS: In the acute phase, none of the patients showed atrophy of the optic disc, while early damage was observed in the GCC average and minimum thickness in 54.54 % and 77.27 % of patients. At 6 months, the rate of patients with RNFL below normal limits increased to 90 % in the RNFL, and 92.85 % and 100 % in the GCC average and minimum GCC respectively. Spearman's coefficients indicated significant relationships of GCC in the acute phase with visual field index and mean deviation in both acute and chronic phases. A significant correlation was also found with location of the defects.
CONCLUSIONS: GCC thickness measurement by OCT is capable of detecting early axonal damage in NAION eyes in the acute phase that cannot be detected by RNFL. GCC defects are significantly correlated with visual field globally and the defect location.

Entities:  

Mesh:

Year:  2014        PMID: 25107540     DOI: 10.1007/s00417-014-2697-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  27 in total

Review 1.  [Applications of optical coherence tomography (OCT) in neuro-ophthalmology].

Authors:  C Kernstock; K Friebe; F Tonagel
Journal:  Klin Monbl Augenheilkd       Date:  2013-09-24       Impact factor: 0.700

2.  Automated segmentation of the macula by optical coherence tomography.

Authors:  Tapio Fabritius; Shuichi Makita; Masahiro Miura; Risto Myllylä; Yoshiaki Yasuno
Journal:  Opt Express       Date:  2009-08-31       Impact factor: 3.894

Review 3.  [Analysis of macular ganglion cell complex (GCC) with spectral-domain optical coherence tomography (SD-OCT) in glaucoma].

Authors:  J-P Renard; J-R Fénolland; H El Chehab; M Francoz; A-M Marill; R Messaoudi; M Delbarre; M Maréchal; S Michel; J-M Giraud
Journal:  J Fr Ophtalmol       Date:  2013-03-29       Impact factor: 0.818

4.  Incidence of nonarteritic anterior ischemic optic neuropathy.

Authors:  M G Hattenhauer; J A Leavitt; D O Hodge; R Grill; D T Gray
Journal:  Am J Ophthalmol       Date:  1997-01       Impact factor: 5.258

5.  Macular ganglion cell-inner plexiform layer: automated detection and thickness reproducibility with spectral domain-optical coherence tomography in glaucoma.

Authors:  Jean-Claude Mwanza; Jonathan D Oakley; Donald L Budenz; Robert T Chang; O'Rese J Knight; William J Feuer
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-21       Impact factor: 4.799

6.  Scanning laser polarimetry, but not optical coherence tomography predicts permanent visual field loss in acute nonarteritic anterior ischemic optic neuropathy.

Authors:  Mark J Kupersmith; Susan Anderson; Mary Durbin; Randy Kardon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-15       Impact factor: 4.799

7.  Macular thickness predictive of visual field sensitivity in ischaemic optic neuropathy.

Authors:  Taras Papchenko; Brian T Grainger; Peter J Savino; Greg D Gamble; Helen V Danesh-Meyer
Journal:  Acta Ophthalmol       Date:  2012-06-13       Impact factor: 3.761

8.  Measurement of local retinal ganglion cell layer thickness in patients with glaucoma using frequency-domain optical coherence tomography.

Authors:  Min Wang; Donald C Hood; Jung-Suk Cho; Quraish Ghadiali; Carlos Gustavo De Moraes; Gustavo V De Moraes; Xian Zhang; Robert Ritch; Jeffrey M Liebmann
Journal:  Arch Ophthalmol       Date:  2009-07

9.  Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis.

Authors:  S Bianchi Marzoli; P Ciasca; M Curone; G Cammarata; L Melzi; A Criscuoli; G Bussone; D D'Amico
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

10.  Comparison of the ganglion cell complex and retinal nerve fibre layer measurements using Fourier domain optical coherence tomography to detect ganglion cell loss in non-arteritic anterior ischaemic optic neuropathy.

Authors:  Saban Gonul; Bengu Ekinci Koktekir; Berker Bakbak; Sansal Gedik
Journal:  Br J Ophthalmol       Date:  2013-06-12       Impact factor: 4.638

View more
  13 in total

1.  Genetic polymorphisms of apolipoprotein E in nonarteritic anterior ischemic optic neuropathy.

Authors:  Yuyu Chou; Zixi Sun; Ye Wang; Yuhan Wang; Jin Ma; Dianxi Zhang; Yong Zhong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-08       Impact factor: 3.535

2.  Early macular ganglion cell-inner plexiform layer analysis in non-arteritic anterior ischemic optic neuropathy.

Authors:  Sang Woo Park; Yong Sok Ji; Hwan Heo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-03       Impact factor: 3.117

3.  Ganglion cell analysis at acute episode of nonarteritic anterior ischemic optic neuropathy to predict irreversible damage. A prospective study.

Authors:  Elisabet De Dompablo; J García-Montesinos; F J Muñoz-Negrete; G Rebolleda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-15       Impact factor: 3.117

4.  Correlations between visual morphological, electrophysiological, and acuity changes in chronic non-arteritic ischemic optic neuropathy.

Authors:  Lucilla Barbano; Lucia Ziccardi; Vincenzo Parisi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-07       Impact factor: 3.117

5.  Clinical Efficacy Observation of Acupuncture Treatment for Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Yali Qin; Wei Yuan; Hui Deng; Zhanmei Xiang; Chao Yang; Xinyun Kou; Shufei Yang; Zhijun Wang; Ming Jin
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-24       Impact factor: 2.629

6.  Peripapillary Retinal Nerve Fiber Layer Swelling Predicts Peripapillary Atrophy in a Primate Model of Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Mary A Johnson; Neil R Miller; Theresa Nolan; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-02       Impact factor: 4.799

7.  Macular Evaluation wıth Spectral Domain Type Optic Coherence Tomography in Eyes with Acute Nonarteritic Ischemic Optic Neuropathy at the Presentation Visit.

Authors:  Oya Donmez; Gamze Kocaoglu; Aylin Yaman; Meltem Soylev Bajin; Ali Osman Saatci
Journal:  Open Ophthalmol J       Date:  2017-01-31

8.  Time Course of Macular and Peripapillary Inner Retinal Thickness in Non-arteritic Anterior Ischaemic Optic Neuropathy Using Spectral-Domain Optical Coherence Tomography.

Authors:  Katsutoshi Goto; Atsushi Miki; Syunsuke Araki; Kenichi Mizukawa; Masaki Nakagawa; Go Takizawa; Yoshiaki Ieki; Junichi Kiryu
Journal:  Neuroophthalmology       Date:  2016-02-25

9.  Difference in patterns of retinal ganglion cell damage between primary open-angle glaucoma and non-arteritic anterior ischaemic optic neuropathy.

Authors:  Yeon Hee Lee; Kyoung Nam Kim; Dong Won Heo; Tae Seen Kang; Sung Bok Lee; Chang-Sik Kim
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

Review 10.  Clinical Usefulness of Spectral-Domain Optical Coherence Tomography in Glaucoma and NAION.

Authors:  Tae Hee Lee; Hwan Heo; Sang Woo Park
Journal:  Chonnam Med J       Date:  2016-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.